Saturday, June 10, 2023 | 10 a.m. – noon
Unwanted outcomes related to medications are the greatest cause of loss for psychiatrists. As we emerge from the COVID public health emergency (PHE), the prescription drug abuse epidemic likely will become a priority again for the nation and for the states. Unfortunately, drug overdose deaths increased during the PHE. Even for psychiatrists who have a long history of safe prescribing practices, renewed focus on laws and regulations and the professional liability risks associated with prescribing controlled and non-controlled substances is called for. Discussion will include issues related to informed consent and prescribing for minors.
At the conclusion of this program, attendees will be able to:
This activity has been designed to meet the educational needs of psychiatrists and other physicians providing clinical care to psychiatric patients.
Planners and Faculty
Charles D. Cash, JD, LLM – Content Developer, Speaker
Associate Director of Risk Management, PRMS
Mr. Cash has no relevant financial relationships with ineligible companies.
Professional Risk Management Services (PRMS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
Professional Risk Management Services (PRMS) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
PRMS does not accept financial support from ineligible companies for CME activities.
Method of Participation
Physicians must attend the live activity and complete a Post Activity Learning Assessment Tool and Credit Application form to receive a Credit Certificate.
Estimated Time to Complete
2.0 hours, exclusive of breaks
The purpose of this activity is to provide general information on risk management issues. The information presented does not constitute legal advice.